Basics Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $5.62B Activated in VL: True Average Daily Range Avg Daily Range: $0.76 | 2.31% Avg Daily Range (30 D): $1.10 | 1.40% Avg Daily Range (90 D): $1.48 | 1.68% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): .88M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 45 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 5,257 Avg Inst. Trade: $3.24M Avg Inst. Trade (30 D): $4.58M Avg Inst. Trade (90 D): $4.76M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.49M Avg Closing Trade (30 D): $12.31M Avg Closing Trade (90 D): $11.3M Avg Closing Volume: 100.96K     News Jul 22, 2025 @ 11:00 AM Lantheus Completes Acquisition of Life Molecular I... Source: Lantheus Holdings, Inc. May 14, 2025 @ 6:50 PM Radiopharmaceuticals Market Products and Applicati... Source: N/A Feb 27, 2025 @ 4:02 PM Lantheus' Pylarify Hit $1B in 2024 Sales Source: David Kretzmann Jan 29, 2025 @ 9:30 AM Why Lantheus Holdings Stock Got Thrashed on Tuesda... Source: Eric Volkman Jan 28, 2025 @ 3:32 PM Lantheus To Buy Evergreen Theragnostics For Over $... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $3.67 $1.06 $-.17 Diluted EPS $3.5 $1.02 $-.19 Revenue $ 1.54B $ 372.76M $ 391.11M Gross Profit $ 984.15M $ 237.7M $ 248.55M Net Income / Loss $ 254.32M $ 72.95M $ -11.79M Operating Income / Loss $ 452.41M $ 102.07M $ 113.87M Cost of Revenue $ 552.55M $ 135.06M $ 142.57M Net Cash Flow $ 220.3M $ 25.73M $ 46.44M PE Ratio 20.24